User profiles for Carolyn J. Anderson

Carolyn J. Anderson

- Verified email at pitt.edu - Cited by 16530

Carolyn J Anderson

- Verified email at illinois.edu - Cited by 3313

The future of nuclear medicine, molecular imaging, and theranostics

WA Weber, J Czernin, CJ Anderson… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Wolfgang A. Weber and Johannes Czernin Scientific discoveries published in The Journal
of Nuclear Medicine over the past 60 years have shaped the practice of medicine and form …

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes

…, EH Wong, AL Rheingold, CJ Anderson - Journal of medicinal …, 2004 - ACS Publications
The increased use of copper radioisotopes in radiopharmaceutical applications has created
a need for bifunctional chelators (BFCs) that form stable radiocopper complexes and allow …

[HTML][HTML] 177Lu-labeled phosphoramidate-based PSMA inhibitors: the effect of an albumin binder on biodistribution and therapeutic efficacy in prostate tumor-bearing …

…, JD Latoche, B Langton-Webster, CJ Anderson… - Theranostics, 2017 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) continues to be an active biomarker for small-molecule
PSMA-targeted imaging and therapeutic agents for prostate cancer and various non-…

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

…, EH Wong, GR Weisman, CJ Anderson - Chemical …, 2010 - ACS Publications
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems. Molecular …

In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy

…, AR Fritzberg, MJ Welch, CJ Anderson - Journal of Nuclear …, 2003 - Soc Nuclear Med
Pretargeting involves administration of a tumor-targeting monoclonal antibody (mAb)
covalently linked to a molecule having a high-affinity binding site for a rapidly distributed …

Efficient production of high specific activity 64Cu using a biomedical cyclotron

…, WH Margeneau, CS Cutler, CJ Anderson… - Nuclear medicine and …, 1997 - Elsevier
Copper-64 (T 1 2 = 12.7 h ) is an intermediate-lived positron-emitting radionuclide that is a
useful radiotracer for positron emission tomography (PET) as well as a promising …

Comparison of Four 64Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model:  Evaluation of New Derivatives for Positron Emission …

…, MA Schmidt, J Wang, CJ Anderson - Journal of medicinal …, 1999 - ACS Publications
Previous studies have shown that modification of the somatostatin analogue octreotide (OC),
by substitution of tyrosine for phenylalanine at position 3 and of a C-terminal carboxylic …

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research

CJ Anderson, R Ferdani - Cancer Biotherapy and …, 2009 - liebertpub.com
Summation Copper-64 (T 1/2 = 12.7 hours; β + , 0.653 MeV [17.8 %]; β − , 0.579 MeV [38.4
%]) has decay characteristics that allow for positron emission tomography (PET) imaging and …

A p* primer: Logit models for social networks

CJ Anderson, S Wasserman, B Crouch - Social networks, 1999 - Elsevier
… Author links open overlay panel Carolyn J Anderson a b , Stanley Wasserman b c d 1 , …
Lastly, we define X ij c as the complement relation for the tie from i to j: X ij c ={X kl , with (k, l)≠(i, j)…

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver

…, M Wang, MJ Welch, CJ Anderson - Bioconjugate …, 2000 - ACS Publications
An understanding of the metabolic fate of radiometal-labeled peptides is important due to
their application in the areas of diagnostic imaging and targeted radiotherapy. Radioisotopes …